MarketPulse
S

$STAA

2 articles found
1 positive
0 negative
1 neutral
BenzingaBenzinga··Vandana Singh

Alcon Terminates LENSAR Merger After FTC Delays Tank Stock 25%

Alcon terminates $14/share LENSAR merger after FTC regulatory delays. LENSAR stock crashes 25.44% to 52-week low of $7.65, destroying shareholder value.
ALCLNSRSTAAstock declineregulatory review
BenzingaBenzinga··Vandana Singh

Staar Surgical Wins FDA Clearance to Expand Implantable Lens Market to Older Patients

Staar Surgical wins FDA approval to expand implantable lens eligibility to patients aged 21-60, up from 21-45, potentially reaching 8 million additional U.S. candidates.
ALCSTAAXHEFDA approvaltechnical analysis